10 Biotech Stocks Being Dumped By Big Money Managers
News | 30 August 2011
Cephalon Inc. (CEPH): Biotechnology Industry. Market cap of $6.27B. Net institutional shares sold over the current quarter at 13.2M, which is 18.67% of the company's 70.71M share float. Relatively low correlation to the market (beta = 0.38), ...
Click on the link to read the full article at Seeking Alpha
(This link will open in a new window)
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
